Skip to main content
SpringerLink
Log in

Animal models of drug withdrawal symptoms

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

There have been few attempts to model subjective symptoms of drug withdrawal using animals as subjects. Two approaches for developing such models are reviewed. First, using drug discrimination methodology, it may be possible to train animals to detect the effects of withdrawal. This method has two difficulties: 1) the only discriminations trained to date involve precipitated withdrawal, and 2) the stimulus controlling behavior is difficult to specify. Second, withdrawal from many drugs of abuse produces the symptom of anxiety, and it seems likely that animal models of anxiety could be useful for studying drug withdrawal. This hypothesis has been explored most fully using subjects trained to detect the discriminative stimulus properties of the putative anxiogenic drug pentylenetetrazole (PTZ). Withdrawal from benzodiazepines or ethanol substitutes fully for PTZ, and withdrawal from cocaine, morphine, and nicotine substitutes partially for PTZ. Emerging data suggest that other animal models of anxiety may also be useful for detecting drug withdrawal. The final portion of this review examines a behavioral test that is very sensitive for detecting physical signs of withdrawal in animals. In subjects maintained on an operant baseline using food as a reinforcer, withdrawal from a drug of dependence frequently is associated with disruption of that operant behavior. For example, tetrahydrocannabinol and cocaine, drugs that are not traditionally seen as having significant withdrawal signs, produce disruption of operant responding when high-dose administration is terminated, and their readministration reverses this behavioral disruption. Based on the observation that withdrawal is associated with anxiogenic stimuli, we suggest a method to determine if disruption of operant behavior may be related to these stimuli.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahlenius S, Engel J (1974) Behavioral sitmulation induced by ethanol withdrawal. Pharmacol Biochem Behav 2:847–850

    Article  PubMed  Google Scholar 

  • Altman J, Albert J, Milstein S, Greenberg J (1977) Drugs as discriminable events in humans. Adv Behav Biol 22:187–206

    Google Scholar 

  • Andrews J, Turski L, Stephens DN (1989) Does the pentylenetetrazole (PTZ) cue reflect PTZ-induced kindling or PTZ-induced anxiogenesis? Drug Dev Res 16:247–256

    Article  Google Scholar 

  • Appel JB, White FJ, Holohean AM (1982) Analyzing mechanism of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Res 6:529–536

    Article  Google Scholar 

  • Aronson T, Craig TJ (1986) Cocaine precipitation of panic disorder. Am J Psychiatry 143:643–645

    PubMed  Google Scholar 

  • Ator N, Cook JM, Griffiths RR (1989) Drug discrimination in pentylenetetrazol-trained baboons: generalization to buspirone and β-carboline-3-carboxylic acid ethyl ester but not lorazepam or pentobarbital. Drug Dev Res 16:257–267

    Article  Google Scholar 

  • Baldwin HA, File SE (1989) Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor. Brain Res Bull 20:603–606

    Article  Google Scholar 

  • Balster RL (1985) Behavioral studies of tolerance and dependence. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Neurology and neurobiology, vol 13. Liss, New York, pp 403–418

    Google Scholar 

  • Balster RL, Woolverton WL (1980) Continuous-access phencyclidine self-administration by rhesus monkeys leading to physical dependence. Psychopharmacology 70:5–10

    Article  PubMed  Google Scholar 

  • Barrett RS, Smith RL (1988) Time dependent pentylenetetrazol-like cues subsequent to diazepam administration. Psychopharmacology 96:169–173

    Article  PubMed  Google Scholar 

  • Beardsley PM, Balster RL, Harris LS (1986) Dependence on tetrahydrocannabinol in rhesus monkeys. J Pharmacol Exp Ther 239:311–319

    PubMed  Google Scholar 

  • Belknap JK (1978) Barbiturate physical dependence in mice: effects of neuroleptics and diazepam on the withdrawal syndrome. Clin Toxicol 12:427–434

    PubMed  Google Scholar 

  • Benjamin D, Emmett-Oglesby MW, Lal H (1987) Modulation of the discriminative stimulus produced by pentylenetetrazole by centrally administered drugs. Neuropharmacology 26:1727–1731

    Article  PubMed  Google Scholar 

  • Bjorkqvist SE (1975) Clonidine in alcohol withdrawal. Acta Psychiatr Scand 52:257–263

    Google Scholar 

  • Blum K, Eubanks JD, Wallace JE, Hamilton H (1976) Enhancement of alcohol withdrawal convulsions in mice by haloperidol. Clin Toxicol 9:427–434

    PubMed  Google Scholar 

  • Bonetti EP, Polc P, Pieri L (1984) An azido analogue of the benzodiazepine antagonist Ro 15-1788 (Ro 15-4513) behaves as a partial inverse benzodiazepine agonist. Neurosci Lett 30(Suppl):18

    Google Scholar 

  • Bozarth MA, Wise RA (1981) Heroin reward is dependent on a dopaminergic function. Life Sci 35:1881–1886

    Article  Google Scholar 

  • Busto U, Sellers EM, Naranjo CA, Cappell HD, Sanchez CM, Sykora K (1986) Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 315:654–659

    Google Scholar 

  • Carrol ME, Lac ST (1987) Cocaine withdrawal produces behavioral disruptions in rat. Life Sci 40:2183–2190

    Article  PubMed  Google Scholar 

  • Carrol ME, Hagen EW, Ascencio M, Brauer LM (1988) Behavioral dependence on caffeine and phencyclidine in rhesus monkeys: interactive effects. Pharmacol Biochem Behav 31:927–932

    Article  PubMed  Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1984) An experimental paradigm for studying the discriminative stimulus properties of drugs in humans. Psychopharmacology 82:272–274

    Article  PubMed  Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1985) The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol andd-amphetamine in humans. Pharmacol Biochem Behav 24:1165–1672

    Google Scholar 

  • Chait LD, Uhlenhuth EH, Johanson CE (1986) The discriminative stimulus and subjective effects ofd-amphetamine, phenmetrazine and fenfluramine in humans. Psychopharmacology 89:301–306

    Article  PubMed  Google Scholar 

  • Charney DS, Riordan CE, Kleber HD, Murburg M, Braverman P, Sternberg DE, Heninger GR, Redmond DE (1982) Clonidine and naltrexone. A safe, effective and rapid treatment of abrupt withdrawal from methadone therapy. Arch Gen Psychiatry 7:669–673

    Google Scholar 

  • Colpaert FC (1978a) Discriminative stimulus properties of narcotic analgesic drugs. Pharmacol Biochem Behav 9:863–887

    Article  PubMed  Google Scholar 

  • Colpaert FC (1978b) Some properties of drugs as physiological signals: the FR procedure and signal detection theory. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier-North, Amsterdam, pp 217–242

    Google Scholar 

  • Colpaert FC (1986) Drug discrimination: behavioral, pharmacological, and molecular mechanisms of discriminative drug effects. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence. Academic Press, New York, pp 161–193

    Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1978) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535–546

    Article  Google Scholar 

  • Costa E, Guidotti A (1985) Endogenous ligands for benzodiazepine recognition sites. Biochem Pharmacol 34:3399–3403

    Article  PubMed  Google Scholar 

  • Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ, Tyers MB (1989a) Inhibition by GR38032F of behavioural effects which follow withdrawal from treatment with drugs of abuse. Br J Pharmacol (in press)

  • Costall B, Domeney AM, Jones BJ, Kelly ME, Gerrard PA, Naylor RJ, Tyers MB (1989b) Influence of GR38032F on the behavioural consequences of ceasing sub-chronic treatment with drugs of abuse. Br J Pharmacol (in press)

  • Courtwright DT (1982) Dark paradise: opiate addiction in America before 1940. Harvard Press, Cambridge, Massachusetts

    Google Scholar 

  • D'Mello GD, Stolerman IP (1977) Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats. Br J Pharmacol 61:415–422

    PubMed  Google Scholar 

  • Dewey WL, Henkins J, O'Rourke T, Harris LS (1972) The effects of chronic administration of trans-delta-9-tetrahydrocannabinol on behavior and the cardiovascular system of dogs. Arch Int Pharmacodyn 198:118–131

    PubMed  Google Scholar 

  • Dorrow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet II:98–99

    Article  Google Scholar 

  • DuMez AG (1919) Increased tolerance and withdrawal phenomena in chronic morphinism. A review of the literature. JAMA 72:1069–1072

    Google Scholar 

  • Emmett-Oglesby MW, Mathis DA (1989) Precipitated withdrawal from chlordiazepoxide as a discriminative stimulus for rats. FASEB J 3:A586

    Google Scholar 

  • Emmett-Oglesby MW, Spencer DG, Elmesallamy F, Lal H (1983a) The pentylenetetrazol model of anxiety detects withdrawal from diazepam in rats. Life Sci 33:161–168

    Article  PubMed  Google Scholar 

  • Emmett-Oglesby MW, Spencer DG Jr, Lewis M, Elmesallamy F, Lal H (1983b) Anxiogenic aspects of diazepam withdrawal can be detected in animals. Eur J Pharmacol 92:127–130

    Article  PubMed  Google Scholar 

  • Emmett-Oglesby MW, Wurst MF, Lal H (1983c) Discriminative stimulus properties of cocaine. Neuropharmacology 22:97–102

    Article  PubMed  Google Scholar 

  • Emmett-Oglesby MW, Spencer DG Jr, Lewis MW, L H (1984) Bioassay of subjective effects associated with benzodiazepine withdrawal in animals: a novel direction in dependence research. In: Harris LS (ed) Proceedings, Committee on Problems of Drug Dependence, National Institute on Drug Abuse Monograph 49. US Government Printing Office, Washington, DC, pp 185–191

    Google Scholar 

  • Emmett-Oglesby MW, Mathis DA, Lal H (1987) Diazepam tolerance and withdrawal assessed in an animal model of subjective drug effects. Drug Dev Res 11:145–156

    Article  Google Scholar 

  • Emmett-Oglesby MW, Mathis DA, Harris CM, Idemudia SO, Lal H (1988a) Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. J Pharmacol Exp Ther 244:892–897

    PubMed  Google Scholar 

  • Emmett-Oglesby MW, Wood DM, Mathis DA, Lal H (1988b) A relationship between withdrawal and tolerance to the discriminative stimulus properties of cocaine. Abstr Soc Neurosci 14:961

    Google Scholar 

  • Fielding S, Wilker J, Hynes M, Szewcak M, Novick W, Lal H (1978) A comparison of clonidine with morphine for antinociceptive and antiwithdrawal actions. J Pharmacol Exp Ther 207:899–905

    PubMed  Google Scholar 

  • File SE (1984a) The neurochemistry of anxiety. In: Burrows GD, Norman TR, Davies B (eds) Antianxiety agents. Elsevier, Amsterdam, pp 13–32

    Google Scholar 

  • File SE (1984b) Behavioral pharmacology of benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 8:19–31

    Article  PubMed  Google Scholar 

  • File SE (1985) Tolerance to the behavioral actions of benzodiazepines. Neurosci Biobehav Rev 9:113–121

    Article  PubMed  Google Scholar 

  • File SE, Baldwin HA (1987) Flumazenil: a possible treatment for benzodiazepine withdrawal anxiety. Lancet II:106–107

    Article  Google Scholar 

  • File SE, Lister RG (1984) Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions? Neuropharmacology 23:393–396

    Google Scholar 

  • File SE, Pellow S (1983) Anxiogenic action of a convulsant benzodiazepine: reversal by chlordiazepoxide. Brain Res 278:370–372

    Article  PubMed  Google Scholar 

  • File SE, Baldwin HA, Hitchcott PK (1989) Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology 98:262–264

    Article  Google Scholar 

  • Fischman MW (1984) The behavioral pharmacology of cocaine in humans. NIDA Res Monogr 50:72–91

    PubMed  Google Scholar 

  • Fischman MW, Schuster CR (1982) Cocaine self-administration in humans. Fed Proc 41:241–246

    PubMed  Google Scholar 

  • Fischman MW, Schuster CR, Hatano Y (1983) A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans. Pharmacol Biochem Behav 18:123–127

    Article  Google Scholar 

  • Ford RD, Balster RL (1976) Schedule-controlled behavior in the morphine-dependent rat. Pharmacol Biochem Behav 4:569–573

    Article  PubMed  Google Scholar 

  • France CP, Woods JH (1987) Morphine, saline and naltrexone discrimination in morphine-treated pigeons. J Pharmacol Exp Ther 242:195–202

    PubMed  Google Scholar 

  • Fredericks AB, Benowitz NL (1980) An abstinence syndrome following chronic administration of delta-9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacology 71:201–202

    Article  PubMed  Google Scholar 

  • Gallager DW, Lakoski JM, Gonsalves SF, Rauch SL (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308:74–77

    Article  PubMed  Google Scholar 

  • Gauvin DV and Young AM (1989) Perceptual masking of drug stimuli. Drug Dev Res 16:151–162

    Article  Google Scholar 

  • Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107–113

    PubMed  Google Scholar 

  • Gellert VF, Holtzman SG (1979) Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 211:595–605

    Google Scholar 

  • Goa KL, Ward A (1986) Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32:114–129

    PubMed  Google Scholar 

  • Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136:1184–1187

    PubMed  Google Scholar 

  • Griffiths JW, Goudie AJ (1987) Analysis of the role of behavioural factors in the development of tolerance to the benzodiazepine midazolam. Neuropharmacology 26:201–209

    Article  PubMed  Google Scholar 

  • Griffiths RR, Bigelow GE, Liebson IA (1986) Human coffee drinking: reinforcing and physical dependence producing effects of caffeine. J Pharmacol Exp Ther 239:416–425

    PubMed  Google Scholar 

  • Guidotti A, Forchetti CM, Corda MG, Konkel D, Bennett CD, Costa E (1989) Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA (in press)

  • Haertzen CA (1966) Development of scales based on patterns of drug effects using the Addiction Research Center Inventory (ARCI). Psychol Rep 18:163–194

    PubMed  Google Scholar 

  • Handley SM, Mithani S (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze exploration model of “fear” motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 327:1–5

    Article  Google Scholar 

  • Harris CM, Lal H (1988) Central nervous system effects of the imidiazodiazepine Ro 15-4513. Drug Dev Res 13:187–203

    Article  Google Scholar 

  • Harris CM, Emmett-Oglesby MW, Robinson NG, Lal H (1986) Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazole (PTZ). Psychopharmacology 90:85–89

    Article  PubMed  Google Scholar 

  • Harris CM, Benjamin D, Lal H (1987) Anxiety-like subjective effect of ethanol antagonist Ro 15-4513 demonstrated in pentylenetetrazole discrimination. Neuropharmacology 26:1545–1547

    Article  PubMed  Google Scholar 

  • Harris CM, Benjamin D, Elkhayat IS, Bhadra S, Lal H (1988) Role of benzodiazepine receptors in treatment but not etiology of ethanol-withdrawal anxiety. Abstr Soc Neurosci 14:963

    Google Scholar 

  • Harris CM, Emmett-Oglesby MW, Lal H (1989) Sensitivity of pentylenetetrazole discrimination increased by a stimulus fading technique. Psychopharmacology 98:460–464

    Article  PubMed  Google Scholar 

  • Harris RT, Walters W, McLendon D (1974) Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacology 37:23–29

    Article  Google Scholar 

  • Harvey SC (1985) Hypnotics and sedatives. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's: the pharmacological basis of therapeutics. Macmillan, New York, pp 339

    Google Scholar 

  • Herling S, Coale EH, Valentino RJ, Hein DW, Woods JH (1980) Narcotic discrimination in pigeons. J Pharmacol Exp Ther 214:139–146

    PubMed  Google Scholar 

  • Holtzman SG (1985a) Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs. J Pharmacol Exp Ther 233:80–86

    PubMed  Google Scholar 

  • Holtzman SG (1985b) Discriminative stimulus properties of opioids that interact with mu, kappa and PCP/sigma receptors. In: Seiden LS, Balster R (eds) Behavioral pharmacology: the current status. Neurology and neurobiology, vol 13. Liss, New York, pp 131–147

    Google Scholar 

  • Holtzman SG, Villareal JE (1973) Operant behavior in the morphine-dependent rhesus monkey. J Pharmacol Exp Ther 184:528–541

    PubMed  Google Scholar 

  • Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 233:80–86

    Google Scholar 

  • Idemudia SO, Lal H (1989) A pentylenetetrazol-like stimulus is produced in rats during withdrawal from ingested chlordiazepoxide. Drug Dev Res 16:23–29

    Article  Google Scholar 

  • Jaffe JJ, Martin WR (1985) Opioid analgesics and antagonists. In: Gilman AG, Goodman L, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 491–531

    Google Scholar 

  • Järbe TUC, Hiltunen AJ (1988) Ethanol and Ro 15-4513: behavior maintained by operant procedures (DRL-72s and PTZ-drug discrimination) in rats. Drug Alcohol Depend 22:83–90

    Article  PubMed  Google Scholar 

  • Johanson CE (1984) Assessment of the dependence potential of cocaine in animals. NIDA Res Monogr 50:54–71

    PubMed  Google Scholar 

  • Jones RT, Benowitz N (1976) The 30-day trip — clinical studies of cannabis tolerance and dependence. In: Braude MC, Szara S (eds) The pharmacology of marihuana. Raven Press, New York, pp 627–642

    Google Scholar 

  • Kalant H, LeBlanc AE, Gibbins (1971) Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacol Rev 23:135–191

    PubMed  Google Scholar 

  • Kales A, Soldatos CR, Bixler EO, Kales JD (1983) Rebound insomnia and rebound anxiety: a review. Pharmacology 26:121–137

    PubMed  Google Scholar 

  • Lader MH (1987) Rational use of anxiolytic drugs. Ration Drug Ther 21:1–5

    Google Scholar 

  • Lal H (1977) Discriminative stimulus properties of drugs. Plenum Press, New York

    Google Scholar 

  • Lal H, Emmett-Oglesby MW (1983) Behavioral analogs of anxiety: animal models. Neuropharmacology 22:1423–1441

    Article  PubMed  Google Scholar 

  • Lal H, Fielding S (1985) Antagonism of discriminative stimuli produced by anxiogenic drugs as a novel approach to bioassay of anxiolytics. Drug Dev Res 4:3–21

    Article  Google Scholar 

  • Lal H, Shearman GT (1980) Interoceptive discriminative stimuli in the development of CNS drugs and a case of an animal model of anxiety. Ann Rep Med Chem 15:51–58

    Google Scholar 

  • Lal H, Miksic C, McCarten M (1978) A comparison of the discriminative stimulus produced by naloxone, cyclazocine and morphine in the rat. In: Colpaert FC, Rosecrans JA (eds), op cit., pp 177–180

  • Lal H, Mann PA, Shearman GT, Lippa AS (1981) Effects of acute and chronic pentylenetetrazole treatment on benzodiazepine and cholinergic receptors binding in rat brain. Eur J Pharmacol 75:115–119

    Article  PubMed  Google Scholar 

  • Lal H, Harris CM, Yaden S, Greene S (1984) Physiological response to pentylenetetrazol in rats: further evidence for its classification as an anxiogenic drug. Abstr Soc Neurosci 10:97

    Google Scholar 

  • Lal H, Harris CM, Benjamin D, Springfield AC, Bhadra S, Emmett-Oglesby MW (1988) Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J Pharmacol Exp Ther 247:508–518

    PubMed  Google Scholar 

  • Lane JD, Sands MP, Co C, Cherek DR, Smith JE (1982) Biogenic monoamine turnover in discrete rat brain regions is correlated with conditioned emotional response and its conditioning history. Brain Res 240:95–108

    Article  PubMed  Google Scholar 

  • Liegghio NE, Yeragani VK, Moore NC (1988) Buspirone-induced jitteriness in three patients with panic disorder and one patient with generalized anxiety disorder. J Clin Psychiatry 49:165–166

    PubMed  Google Scholar 

  • Little HJ, Nutt DJ, Taylor SC (1984) Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling. Br J Pharmacol 83:951–958

    PubMed  Google Scholar 

  • Little HJ, Nutt DJ, Taylor SC (1987a) Kindling and withdrawal changes at the benzodiazepine receptor. J Psychopharmacol 1:35–46

    Google Scholar 

  • Little HJ, Nutt DJ, Taylor SC (1987b) Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Res Bull 19:371–378

    Article  PubMed  Google Scholar 

  • Littleton J, Little HJ (1989) Adaptation in neuronal calcium channels as a common basis for physical dependence on central depressant drugs. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana Press, Clifton, New Jersey, pp 461–518

    Google Scholar 

  • Lucki I (1988) Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion. J Pharmacol Exp Ther 247:1120–1127

    PubMed  Google Scholar 

  • Lucki I, Rickels K, Geller AM (1986) Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 88:426–433

    Article  PubMed  Google Scholar 

  • Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163–171

    Article  PubMed  Google Scholar 

  • Marks J (1978) The benzodiazepines: use, overuse, misuse, abuse. MTP Press, Lancaster, England

    Google Scholar 

  • Martin WR, Sloan JW (1977) Neuropharmacology and neurochemistry of subjective effects, analgesia, tolerance, and dependence produced by narcotic analgesics. In: Martin WR (ed) Handbook of experimental pharmacology, vol 45/I, drug addiction I: morphine, sedative/hypnotic and alcohol dependence. Springer, Berlin Heidelberg New York, pp 43–158

    Google Scholar 

  • Mathis DA, Emmett-Oglseby MW (1989a) Pentobarbital blocks the pentylenetetrazol-like effect of withdrawal from chronic diazepam. Drug Dev Res 16:285–293

    Article  Google Scholar 

  • Mathis DA, Emmett-Oglesby MW (1989b) Rebound pentylenetetrazole-substitution by rats after a single large-dose of midazolam. Abstr Soc Neurosci 15:61

    Google Scholar 

  • McNicholas LF, Martin WR (1982) The effect of a benzodiazepine antagonist, Ro 15-1788, in diazepam-dependent rats. Life Sci 31:731–737

    Article  PubMed  Google Scholar 

  • Michaelis RC, Holohean AM, Criado JR, Harland RD, Hunter GA, Holloway FA (1988) The chlordiazepoxide/pentylenetetrazole discrimination: characterization of drug interactions and homeostatic responses to drug challenges. Psychopharmacology 96:15–20

    PubMed  Google Scholar 

  • Miksic S, Shearman GT, Lal H (1981) Discriminative response control by naloxone in morphine pretreated rats. Psychopharmacology 72:179–184

    Article  PubMed  Google Scholar 

  • Miyata M, Mocchetti I, Ferrarese C, Guidotti A, Costa E (1987) Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine receptor. J Psychopharmacol 1:35–46

    Google Scholar 

  • Moser PC (1989) An evaluation of the elevated plus-maze using the novel anxiolytic buspirone. Psychopharmacology 99:48–53

    Article  PubMed  Google Scholar 

  • Mossberg D, Liljeberg P, Borg S (1985) Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol 2:551–553

    Article  PubMed  Google Scholar 

  • Norton PRE (1970) The effects of drugs on barbiturate withdrawal convulsions in the rat. J Pharm Pharmacol 27:763–766

    Google Scholar 

  • Nutt DJ (1986) Benzodiazepine dependence in the clinic: reason for anxiety? TIPS 7:457–460

    Google Scholar 

  • Nutt DJ, Costello MJ (1988) Rapid induction of lorazepam dependence and reversal with flumazenil. Life Sci 43:1045–1053

    Article  PubMed  Google Scholar 

  • Olajide D, Lader M (1987) A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. J Clin Psychopharmacol 7:148–152

    PubMed  Google Scholar 

  • Olsen RW, Venter JC (1986) Benzodiazepine/GABA receptors and chloride channels: structural and functional properties. Liss, New York

    Google Scholar 

  • Onaivi ES, Mitchell J, Green MR, Martin BR (1989) Predicting drugs with abuse potential using a mouse anxiety model. FASEB J 3:A587

    Google Scholar 

  • Overton DA (1982) Comparison of the degree of discriminability of various drugs using the t-maze drug discrimination paradigm. Psychopharmacology 76:385–395

    Article  PubMed  Google Scholar 

  • Overton DA (1984) State dependent learning and drug discriminations. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of Psychopharmacology, vol 18. Plenum Press, New York, pp 59–127

    Google Scholar 

  • Overton DA (1987) Applications and limitations of the drug discrimination method for the study of drug abuse. In: Bozarth MA (ed) Methods for assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg New York, pp 291–340

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) The validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Article  PubMed  Google Scholar 

  • Peroutka SJ (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry 20:971–979

    Article  PubMed  Google Scholar 

  • Petersen RC, Stillman RC (eds) (1978) Phencyclidine (PCP) abuse: an appraisal. NIDA Research Monograph 21. US Government Printing Office, Washington DC

    Google Scholar 

  • Petursson H, Lader M (1981) Benzodiazepine dependence. Br J Addict 76:133–145

    PubMed  Google Scholar 

  • Pich EM and Samanin R (1986) Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine. Psychopharmacology 89:125–130

    Article  PubMed  Google Scholar 

  • Rall TW, Schleifer SL (1985) Drugs effective in the therapy of the epilepsies. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) op cit, pp 446–472

    Google Scholar 

  • Rodin EA and Calhoun HD (1970) Metrazol tolerance in a ‘normal’ volunteer population. J Psychiatr Res 13:65–76

    Google Scholar 

  • Roelofs SMGJ (1985) Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2:501–505

    Article  PubMed  Google Scholar 

  • Schuster CR (1968) Variables affecting the self-administration of drugs by rhesus monkeys. In: Vagtborg H (ed) Use of nonhuman primates in drug evaluation. University of Texas Press, Austin, pp 283–299

    Google Scholar 

  • Schuster CR, Balster RL (1977) The discriminative stimulus properties of drugs. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology, vol 1. Academic Press, New York, pp 85–138

    Google Scholar 

  • Schuster CR, Thompson T (1969) Self-administration of and behavioral dependence on drugs. Annu Rev Pharmacol 9:483–502

    Article  PubMed  Google Scholar 

  • Sepinwall J, Cook L (1978) Behavioral pharmacology of antianxiety drugs. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 13: biology of mood and antianxiety drugs. Plenum Press, New York, pp 345–393

    Google Scholar 

  • Shearman GT, Lal H (1980) Generalization and antagonism studies with convulsant, GABAergic and antioconvulsant drugs in rats trained to discriminate pentylenetetrazol from saline. Neuropharmacology 19:473–479

    Article  PubMed  Google Scholar 

  • Shearman GT, Lal H (1981) Discriminative stimulus properties of cocaine related to an anxiogenic action. Prog Neuropsychopharmacol 5:57–63

    Article  PubMed  Google Scholar 

  • Siegel RK (1977) Cocaine: recreational use and intoxication. In: Petersen RC, Stillman RC (eds) Cocaine. US Government Printing Office, Washington, pp 369–380

    Google Scholar 

  • Siegel S (1989) Pharmacological conditioning and drug effects. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana Press, Clifton, New Jersey, pp 115–180

    Google Scholar 

  • Shippenberg TS, Emmett-Oglesby MW, Ayesta FJ, Herz A (1988) Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology 96:110–115

    PubMed  Google Scholar 

  • Shippenberg TS, Emmett-Oglesby MW, Herz A (1989) Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity. Pharmacol Biochem Behav 32:129–132

    Article  PubMed  Google Scholar 

  • Slifer BL, Balster RL (1983) Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkey. J Pharmacol Exp Ther 225:522–528

    PubMed  Google Scholar 

  • Slifer BL, Balster RL, Woolverton WL (1984) Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys. J Pharmacol Exp Ther 230:399–406

    PubMed  Google Scholar 

  • Smith CM (1977) The pharmacology of sedative/hypnotics, alcohol, and anesthetics: sites and mechanisms of action. In: Martin WR (ed) Drug addiction I: morphine, sedative/hypnotics and alcohol dependence. Handbuch der experimentellen pharmakologie, vol 45, Pt 1. Springer, Berlin Heidelberg New York, pp 413–587

    Google Scholar 

  • Spealman RD (1986) Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines. Psychopharmacology 88:398–400

    Article  PubMed  Google Scholar 

  • Steinfels GF, Young GA (1981) Effects of narcotic abstinence on schedule-controlled behavior in dependent rats. Pharmacol Biochem Behav 14:393–395

    Article  PubMed  Google Scholar 

  • Stephens DN, Kehr W (1985)β-carbolines can enhance or antagonize the effects of punishment in mice. Psychopharmacology 85:143–147

    Article  PubMed  Google Scholar 

  • Stephens DN, Schneider HH (1985) Tolerance for the benzodiazepine diazepam in an animal model of anxiolytic activity. Psychopharmacology 87:322–327

    Article  PubMed  Google Scholar 

  • Stephens DN, Kehr W, Schneider HH, Schmiechen R (1984a) Characterisation of agonist, inverse agonist and partial agonist activities of beta-carbolines in a drug discrimination paradigm. Behav Brain Res 12:233–244

    Article  Google Scholar 

  • Stephens DN, Shearman GT, Kehr W (1984b) Discriminative stimulus properties of beta-carbolines characterized as agonists and inverse agonists at central benzodiazepine receptors. Psychopharmacology 83:233–239

    Article  PubMed  Google Scholar 

  • Stephens DN, Schneider HH, Kehr W, Jensen LH, Petersen E, Honore T (1987) Modulation of anxiety byβ-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy. Brain Res Bull 19:309–318

    Article  PubMed  Google Scholar 

  • Swerdlow NR, Gilbert D, Koob GF (1989) Conditioned drug effects on spatial preference: critical evaluation. In: Boulton AA, Baker GB, Greenshaw A (eds) Neuromethods, vol 13, psychopharmacology I. Humana Press, Clifton, New Jersey (in press)

    Google Scholar 

  • Valentino RJ, Herling S, Woods JH (1983) Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons. J Pharmacol Exp Ther 224:307–313

    PubMed  Google Scholar 

  • Vellucci SV, File SE (1979) Chlordiazepoxide loses its anxiolytic action with long-term treatment. Psychopharmacology 62:61–65

    Article  PubMed  Google Scholar 

  • Weissman A (1978) The discriminability of naloxone in rats depends on concomitant morphine treatment. In Colpaert FC, Rosecrans JA (eds), op cit., pp 209–214

    Google Scholar 

  • Weissman BA, Barrett JE, Brady LS, Witkin JM, Mendelson WB, Paul SM, Skolnick P (1984) Behavioral and neurochemical studies on the anticonflict actions of buspirone. Drug Dev Res 4:83–93

    Article  Google Scholar 

  • Wikler A (1980) Opioid dependence: mechanisms and treatment. Plenum Press, New York

    Google Scholar 

  • Wikler A, Fraser HF, Isbell H (1953) N-Allylnormorphine: effects of single doses and precipitation of acute “abstinence syndromes” during addiction to morphine, methadone or heroin in man (post-addicts). J Pharmacol Exp Ther 109:8–20

    PubMed  Google Scholar 

  • Wolgin DL (1989) The role of instrumental learning in behavioral tolerance to drugs. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana Press, Clifton, New Jersey, pp 17–114

    Google Scholar 

  • Wood DM, Emmett-Oglesby MW (1986) Characteristics of tolerance, recovery from tolerance, and cross-tolerance to cocaine used as a discriminative stimulus. J Pharmacol Exp Ther 237:120–125

    PubMed  Google Scholar 

  • Wood DM, Emmett-Oglesby MW (1988) Substitution and cross-tolerance profiles of anorectic drugs in rats trained to detect the discriminative stimulus properties of cocaine. Psychopharmacology 95:364–368

    Article  PubMed  Google Scholar 

  • Wood DM, Ranschaert ER, Lal H (1987) Interoceptive stimuli produced by cocaine are blocked during diazepam withdrawal. Drug Dev Res 11:45–51

    Article  Google Scholar 

  • Wood DM, Laraby PR, Lal H (1989) A pentyleneterazol-like stimulus during cocaine withdrawal: blockade by diazepam and not haloperidol. Drug Dev Res 16:269–276

    Article  Google Scholar 

  • Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251–413

    PubMed  Google Scholar 

  • Woolverton WL, Kleven MS (1988) Evidence for cocaine dependence in monkeys following a prolonged period of exposure. Psycopharmacology 94:288–291

    Google Scholar 

  • Young AM, Sannerud CA (1989) Tolerance to drug discriminative stimuli. In: Goudie AJ, Emmett-Oglesby MW (eds) Psychoactive drugs: tolerance and sensitization. Humana Press, Clifton, NJ, pp 221–278

    Google Scholar 

  • Young R, Glennon RA (1986) Discriminative stimulus properties of amphetamine and structurally related phenylalkylamines. Med Res Rev 6:99–130

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Texas College of Osteopathic Medicine, 3500 Camp Bowie Boulevard, 76107-2690, Fort Worth, TX, USA

    M. W. Emmett-Oglesby, D. A. Mathis, R. T. Y. Moon & H. Lal

Authors
  1. M. W. Emmett-Oglesby
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. A. Mathis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. T. Y. Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Lal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emmett-Oglesby, M.W., Mathis, D.A., Moon, R.T.Y. et al. Animal models of drug withdrawal symptoms. Psychopharmacology 101, 292–309 (1990). https://doi.org/10.1007/BF02244046

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244046

Key words

Search

Navigation